HomeTagsAscentage Pharma

Ascentage Pharma

Biotechnology

Ascentage Pharma Announces IND Approval in China for Phase I Study of APG-5918

PR Newswire - November 10, 2022

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that its novel...

Biotechnology

AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387

PR Newswire - November 7, 2022

Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that it has...

Biotechnology

EHA 2022 | Ascentage Pharma Releases Encouraging Results of Bcl-2 Inhibitor Lisaftoclax (APG-2575)

PR Newswire - June 14, 2022

Ascentage Pharma , a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, announced that it...

ADDING MULTIMEDIA Isuzu Invests US$30 Million in Gatik to Develop Autonomous…

Temenos launches the first Responsible Generative AI solutions for core banking

LibDib Announces Integration with Diverse Powered Brands™ to Amplify Diversity in…

Advantest Unveils New Ultra-High-Current Power Supply for V93000 EXA Scale SoC…

Ascentage Pharma

Hot Topics

ADDING MULTIMEDIA Isuzu Invests US$30 Million in Gatik to Develop Autonomous Driving Logistics Business

Temenos launches the first Responsible Generative AI solutions for core banking

LibDib Announces Integration with Diverse Powered Brands™ to Amplify Diversity in Beverage Distribution